| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/23/2011 | CN101981015A 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101981009A 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101979639A Dendrobium polysaccharide with hypoglycemic activity and extracting method thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101979077A Traditional Chinese medicine for treating heart cerebrovascular diseases |
| 02/23/2011 | CN101979064A Traditional Chinese medicine for treating diabetic limb amputation |
| 02/23/2011 | CN101979063A Chinese medicament for treating diabetic foot |
| 02/23/2011 | CN101979062A Chinese medicament for treating diabetic nephropathy |
| 02/23/2011 | CN101979054A Traditional Chinese medicine for treating diabetic constipation |
| 02/23/2011 | CN101979052A Method for establishing high-performance liquid chromatography (HPLC) fingerprint of Guangxi dendrobium candidum wall. ex lindl and standard fingerprint of Guangxi dendrobium candidum wall. ex lindl |
| 02/23/2011 | CN101979050A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 02/23/2011 | CN101979049A Chinese medicament for treating diabetic coronary heart disease |
| 02/23/2011 | CN101979042A Traditional Chinese medicament for treating diabetic peripheral neuropathy |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |
| 02/23/2011 | CN101979030A Chinese medicinal ointment formula and preparation method and application thereof |
| 02/23/2011 | CN101979027A Method for detecting Jinze coronary disease capsules |
| 02/23/2011 | CN101979012A Chinese medicament for treating diabetic retinopathy |
| 02/23/2011 | CN101979007A Traditional Chinese medicine for treating diabetic heart disease |
| 02/23/2011 | CN101978989A Chinese medicament for treating diabetic diarrhea |
| 02/23/2011 | CN101978979A Method for preparing refined celery extract |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978967A Cattle colostrum calcium tablet |
| 02/23/2011 | CN101978965A Use of medicine in treating diabetes |
| 02/23/2011 | CN101978958A Nutraceutical composition for the treatment of muscle wasting |
| 02/23/2011 | CN101978956A Metformin hydrochloride enteric-coated tablets and preparation method thereof |
| 02/23/2011 | CN101978954A Preparation and application of chitosan particles |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/23/2011 | CN101978949A Gamma-linolenate fat emulsion intravenous injection and preparation method thereof |
| 02/23/2011 | CN101574323B Migltol microcapsule tablet and preparation method thereof |
| 02/23/2011 | CN101249100B Compound formula to supplement protein and manufacture method thereof |
| 02/22/2011 | US7894769 Wireless microphone communication system |
| 02/22/2011 | US7893297 Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893048 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892582 Composition for oral administration containing capsaicinoids |
| 02/22/2011 | CA2609667C Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| 02/22/2011 | CA2601515C Compounds having immunomodulator activity |
| 02/22/2011 | CA2501021C Pantethine-containing particulate |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2435877C Prevention of diabetes by administration of gnrh antagonists |
| 02/22/2011 | CA2435714C Fenofibrate tablets |
| 02/17/2011 | WO2011020120A2 Multi-transgenic pigs for diabetes treatment |
| 02/17/2011 | WO2011020095A2 Compositions and methods of treating inflammation |
| 02/17/2011 | WO2011019400A2 Enhancement of cellular transplantation using small molecule modulators hepatocyte growth factor (scatter factor) activity |
| 02/17/2011 | WO2011018896A1 Production method for astaxanthin-containing composition |
| 02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |
| 02/17/2011 | WO2011018582A2 Floating microgranules |
| 02/17/2011 | WO2011018580A1 Chromium and yeast beta-glucan compositions for preventing and/or treating diabetes |
| 02/17/2011 | WO2011018534A1 Composition based on extra virgin olive oils |
| 02/17/2011 | WO2011017907A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | WO2011017800A1 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid |
| 02/17/2011 | WO2010146078A3 Novel uses of hydroxyproline compositions |
| 02/17/2011 | WO2010143140A3 Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof |
| 02/17/2011 | WO2010123845A3 Siderophore conjugate immunogenic compositions and vaccines |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | WO2010084169A3 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/17/2011 | US20110040144 Method and apparatus for weight control by olfactory nerve ablation |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 02/17/2011 | US20110039911 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039897 Liquid formulation for deferiprone with palatable taste |
| 02/17/2011 | US20110039893 Gsk-3beta inhibitor |
| 02/17/2011 | US20110039886 Enhanced erythropoiesis and iron metabolism |
| 02/17/2011 | US20110039883 Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039870 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/17/2011 | US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii |
| 02/17/2011 | US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 02/17/2011 | US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/17/2011 | US20110039847 Amide derivatives as sirtuin modulators |
| 02/17/2011 | US20110039837 Oxadiazoanthracene compounds for the treatment of diabetes |
| 02/17/2011 | US20110039835 Substituted arylamide diazepinopyrimidone derivatives |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 02/17/2011 | US20110039821 Fused Phenyl Amido Heterocyclic Compounds |
| 02/17/2011 | US20110039811 Treating hyperglycemia with 25-hydroxyvitamin d3 |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | US20110039799 A1 adenosine receptor agonist polymorphs |
| 02/17/2011 | US20110039796 Natural Composition for Anti-Angiogenesis and Anti-Obesity |
| 02/17/2011 | US20110039771 Small humanin-like peptides |
| 02/17/2011 | US20110039770 Inhibitors of protein kinase c isoforms and uses thereof |
| 02/17/2011 | US20110039769 Insulin albumin conjugates |
| 02/17/2011 | US20110039768 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same, |
| 02/17/2011 | US20110039767 Food compositions |
| 02/17/2011 | US20110039766 Methods for preventing or treating metabolic syndrome |